- Location
monoclonal antibodies
"-
GE Healthcare, Sealed Air Expand Alliance to Develop Films for Bioprocessing Applications
Aug 24, 2016GE Healthcare’s Life Sciences business has entered into an agreement with Sealed Air to further develop new films for bioprocessing applications. The companies will develop novel films for single-use bioprocess systems, as part of ...
Tags: GE Healthcare, Sealed Air, Life Sciences
-
Creative Biolabs Has Always Been Highly Recommended Through The Whole Industry
Dec 2, 2014Humanization is significant for reducing the immunogenicity of monoclonal antibodies derived from rodent sources and for improving their activation of the human immune system. Rodent antibodies are highly immunogenic in humans, which ...
Tags: monoclonal antibodies, immune system, Health
-
Covagen Announced It Has Secured CHF42m in a Tranched Series B Financing
Dec 11, 2013Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
-
Separation Media Is Launched by Tosoh
Nov 27, 2013Newly developed Toyopearl AF-r Protein A HC-650F introduced by Tokyo company. Tosoh has launched its newly developed separation media Toyopearl AF-r Protein A HC-650F. The biopharmaceutical industry is growing rapidly in many developed, ...
Tags: Separation Media, Tosoh, Toyopearl
-
The FDA Has Approved Nexavar for The Treatment of Locally Recurrent or Metastatic
Nov 26, 2013Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...
-
IBM Research and IBN Discover Deliver Treatment More Efficiently to Fight Breast Cancer
Nov 5, 2013Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
-
KARO Has Achieved Its First Milestone in a Research Agreement with Pfizer
Sep 9, 2013Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...
-
KU Leuven and FIT Biotech Reached a Global License and Partnership Agreement
Aug 2, 2013KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...
-
Compugen Is Developing a PSB Infrastructure Platform
Jul 19, 2013Israeli Drug discovery company Compugen is developing a Predictive Structural Biology (PSB) infrastructure platform to identify the functional interaction sites of proteins, which are useful in the rational design of novel drugs. Intended ...
-
Lpath Has Won a US patent
May 31, 2013Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...
-
Beckman Coulter Life Sciences Is Expanding Flow Cytometry Portfolio with 14 New Antibodies
Feb 1, 2013Beckman Coulter Life Sciences is expanding their flow cytometry portfolio with the addition of 14 new human monoclonal antibodies from Trillium Diagnostics LLC. The analyte specific reagents (ASRs) provide high specificity, convenience and ...
-
AIMM Therapeutics Collaborated to Develop Oral Diagnostic and Therapeutic Antibodies
Dec 27, 2012Therapeutic antibody company AIMM Therapeutics has collaborated with Italy-based Cosmo Pharmaceuticals to develop oral diagnostic and therapeutic antibodies for gastrointestinal diseases, including colon carcinoma. As part of the ...
-
Genentech Received US FDA Approval of Priority Review Designation for Trastuzumab BLA
Dec 7, 2012Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...
-
CST Has Developed Monoclonal Antibody Discovery Platform, NG-XMT
Nov 29, 2012Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone ...
Tags: NG-XMT, clone, monoclonal antibodies
-
Medistem and Superview Biotechnology Collaborate for Development of Stem Cell Technology.
Nov 29, 2012Medistem and Superview Biotechnology, a subsidiary of Yinhuan Holding Co from Yixing, collaborate for the development of therapeutics using antibody and stem cell technology. The collaboration will leverage proprietary stem cell lines ...
Tags: therapeutics, antibody and stem cell technology, regenerative medicine
Related Products
-
Single Use Bioreactor Recombination Protein and Monoclonal Antibody
-
Hot sale monoclonal antibody KL-6 with high quality and competitive price
-
Aseptic Inspection Isolator for Monoclonal Antibody Production Monitoring with CE
-
Biotech Reactor/Pharmaceutical Bioreactors for Monoclonal Antibody Production Bioreactors Medical Machine/Equipment
-
Weighing Room Solutions for Monoclonal Antibody Development
-
Biotech Reactor/Pharmaceutical Bioreactors for Monoclonal Antibody Production Bioreactors Medical Machine/Equipment
